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Abstract
Background: As part of the Global Programme to Eliminate Lymphatic Filariasis (LF), American Samoa conducted mass drug
administration (MDA) from 2000–2006, and passed transmission assessment surveys in 2011–2012. We examined the
seroprevalence and spatial epidemiology of LF post-MDA to inform strategies for ongoing surveillance and to reduce
resurgence risk.
Methods: ELISA for LF antigen (Og4C3) and antibodies (Wb123, Bm14) were performed on a geo-referenced serum bank of
807 adults collected in 2010. Risk factors assessed for association with sero-positivity included age, sex, years lived in
American Samoa, and occupation. Geographic clustering of serological indicators was investigated to identify spatial
dependence and household-level clustering.
Results: Og4C3 antigen of .128 units (positive) were found in 0.75% (95% CI 0.3–1.6%) of participants, and .32 units
(equivocal plus positive) in 3.2% (95% CI 0.6–4.7%). Seroprevalence of Wb123 and Bm14 antibodies were 8.1% (95% CI 6.3–
10.2%) and 17.9% (95% CI 15.3–20.7%) respectively. Antigen-positive individuals were identified in all ages, and antibody
prevalence higher in older ages. Prevalence was higher in males, and inversely associated with years lived in American
Samoa. Spatial distribution of individuals varied significantly with positive and equivocal levels of Og4C3 antigen, but not
with antibodies. Using Og4C3 cutoff points of .128 units and .32 units, average cluster sizes were 1,242 m and 1,498 m,
and geographical proximity of households explained 85% and 62% of the spatial variation respectively.
Conclusions: High-risk populations for LF in American Samoa include adult males and recent migrants. We identified
locations and estimated the size of possible residual foci of antigen-positive adults, demonstrating the value of spatial
analysis in post-MDA surveillance. Strategies to monitor cluster residents and high-risk groups are needed to reduce
resurgence risk. Further research is required to quantify factors contributing to LF transmission at the last stages of
elimination to ensure that programme achievements are sustained.
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Introduction
Lymphatic filariasis (LF) is a neglected tropical disease of global
importance, with an estimated 1.4 billion people in 73 countries at
risk of infection. Over 120 million people worldwide are currently
affected by lymphatic filariasis and 40 million are disfigured and
disabled [1]. Infection is transmitted by mosquito vectors including
Anopheles, Aedes, Culex and Mansonia species.
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The Pacific Programme for Elimination of Lymphatic Filariasis
(PacELF) was formed in 1999, and as part of the Global
Programme to Eliminate LF (GPELF), aimed to eliminate the
disease as a public health problem in 22 Pacific Island countries
and territories (PICTs) by 2020 [2]. The Programme in the Pacific
covers over 3000 islands and 8.6 million people, and consists of
two strategies: firstly, to interrupt transmission through mass drug
administration (MDA) using albendazole and diethycarbamazine
(DEC) and secondly, to control morbidity and disability of affected
persons [2]. Baseline surveys conducted in 1999 and 2000
determined that 11 PICTs were endemic for LF, five partially
endemic, and six non-endemic [2]. Since then, variable progress
has been made towards reducing prevalence and interrupting
transmission on different islands [3], but significant success has
been achieved in the Samoan Islands, particularly in American
Samoa.
Before the 1960s, both Samoa (formerly called Western Samoa)
and American Samoa had high prevalence (,20%) of lymphatic
filariasis [4,5]. Multiple rounds of MDA in the 1960s had
considerable impact and reduced the prevalence of microfilarae-
mia to less than 2%, but neither Samoa nor American Samoa
managed to achieve sustained interruption of transmission at that
time [6–9]. By 1999, antigen prevalence of 16.5% (N=3018) was
recorded in American Samoa and 4.5% (N=7006) in Samoa. In
American Samoa, after seven rounds of MDA from 2000–2006,
antigen prevalence dropped to 2.3% (N=1881) in 2007 in a
community cluster survey that involved all age groups [10].
Current WHO guidelines [11] recommend that in areas where
W. bancrofti is endemic and Aedes is the principal vector, the
target threshold for post-MDA transmission assessment surveys
(TAS) is,1% antigenaemia. Based on this target and sample sizes,
critical cutoff values are calculated so that evaluation units have at
least a 75% chance of passing if the true prevalence of
antigenaemia is 0.5%, and no more than 5% of passing
(incorrectly) if the true prevalence is $1%. For evaluation units
where the number of antigen-positive individuals is below the
critical cutoff value, no further MDA is recommended because of
the low risk of continuing transmission. For areas where Anopheles
or Culex is the principal vector, the target threshold is ,2%
antigenaemia.
American Samoa passed transmission assessment surveys (TAS)
in 2011–12, designed to determine whether antigen prevalence
using the ICT card test in 6 to 7 year old children was less than 1%
[11]. The surveys found two ICT-positive children (N= 949,
included 25 of 26 schools, critical cutoff of 6) on the main island of
Tutuila and the adjacent island of Aunu’u, and 0% (N=37, census
at all schools) in the remote Manu’a islands [12]. In Samoa, TAS
conducted in 2013 in three evaluation units (N= 3,585) found that
while two units passed established targets, one unit (northwest
Upolu) failed with 19 positives (N= 1,271, critical cutoff of 7) and
further MDA was recommended [13].
The historical high risk of resurgence in the Samoan islands is
likely to be related to a combination of factors, including poor
MDA coverage and low compliance [14]; both day and night-
biting mosquito vectors (including Aedes polynesiensis and Aedes
samoanus) that are highly efficient at transmitting LF [15,16]; and
intense environmental drivers for transmission such as the tropical
climate, high rainfall, abundance of suitable mosquito breeding
sites, and outdoor lifestyle. Samoa and American Samoa were
historically and ethnically one nation, divided into two separate
political entities in 1899. There are continuing strong family,
cultural, and economic links between the Samoan islands, with
associated frequent high-volume travel (often for extended periods)
and cross-migration. Reintroduction of parasites by infected
travellers could therefore play an important role in potential
resurgence [8,17].
Previous studies in Samoa and Haiti found significant micro-
spatial clustering of infection in areas of low prevalence, suggesting
the potential for small residual foci of transmission at the
neighbourhood scale even though overall average prevalence in
an evaluation unit might be less than 1% [18,19]. Such findings
could potentially have significant implications for post-MDA
surveillance strategies in certain epidemiological settings.
The WHO and GPELF have identified a number of knowledge
gaps, key challenges and operational research priorities for LF
elimination, including: i) the significance of residual microfilarae-
mia and antigenaemia in communities where the target threshold
level has been achieved through MDA; ii) rapid identification of
high-prevalence areas and development of strategies for dealing
with them; and iii) development and standardization of cost-
effective strategies for post-MDA surveillance [20]. While the
initial phases of the programme focused mostly on developing
guidelines, initiating and implementing country activities, and
scaling up MDA rapidly to aim for full coverage, the latter phases
require more attention towards ensuring a successful ending [21].
The sustained success of elimination programs depends on careful
monitoring for potential resurgence post-MDA, particularly where
there are residual foci with high prevalence, and where resurgence
has historically proven to be a problem despite achieving low
prevalence rates. The priorities in the endgame phase of LF
elimination therefore include: i) intensive targeted studies of
transmission thresholds, ii) new tools and strategies to accurately
verify when transmission has been interrupted; and iii) effective
post-intervention surveillance, monitoring, and evaluation to
ensure timely detection of resurgence [21]. Additionally, as
countries move closer to elimination, increasingly specific strate-
gies and technical support are needed because of differences in
local settings, needs, resources, constraints, and challenges [21].
Furthermore, as prevalence drops to very low levels after successful
MDA, increasingly statistically robust surveillance strategies will be
required to identify any ongoing transmission, particularly if
confined to small geographic foci.
Currently, TAS typically include young children and do not
provide any information on adults. Adults are the main reservoirs
Author Summary
Lymphatic filariasis (LF) is caused by infection with filarial
worms that are transmitted by mosquito bites. Globally,
120 million people are affected, and 40 million are
disfigured and disabled by complications such as severe
swelling of the legs (elephantiasis). The Global Programme
to Eliminate LF (GPELF) aims to interrupt disease
transmission through mass drug administration (MDA),
and to control illness and suffering in affected persons. In
American Samoa, significant progress has been made
towards LF elimination, and antigen prevalence has
dropped from 16.5% in 1999 to ,1% in 2011/2012 after
seven rounds of MDA. Current challenges include identi-
fication of any residual hotspots of ongoing transmission,
and effective strategies for early identification of any
resurgence. Our study examined the prevalence and
spatial distribution of LF antigens and antibodies in
American Samoan adults to improve understanding of LF
transmission in an area of low prevalence, develop tools
and strategies to more accurately verify interruption of
transmission, and provide evidence-based guidance for
future elimination strategies in American Samoa.
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of any residual infections and are also susceptible to new
infections, so surveillance of adults in the post-MDA phase of
elimination programs could provide valuable information for
identifying residual foci and detecting early resurgence. The
current WHO guidelines encourage cost-efficient methods for
post-MDA surveillance, such as the integration of LF surveillance
activities with other population-based surveys as well as opportu-
nistic screening of groups such as military recruits, hospital
patients, and blood donors for microfilaraemia, antigenaemia, or
antibodies [11]. Such activities will become increasingly important
for GPELF as more countries reach elimination targets and move
into the surveillance phase, but there is currently a paucity of
evidence-based guidelines for conducting these activities or
interpreting the findings.
We examined the seroprevalence of LF antigens and antibodies
in American Samoan adults in 2010 to complement the results of
TAS conducted in young children in 2011–2012, with the goal of
providing a more complete picture of the status of LF in American
Samoa after successful MDA. We used a serum bank and
associated geo-referenced database to determine the seropreva-
lence of LF antigen and antibodies in adults, examine the spatial
epidemiology of infection post-MDA, and identify any possible
residual foci of infection and/or high-risk populations that might
require targeted surveillance and monitoring. Our study aimed to
address some of the knowledge gaps identified by WHO and
GPELF by improving understanding of LF transmission in an area
of low prevalence, explore the value of adult serological data for
surveillance after successful MDA, develop new tools and
strategies to more accurately verify interruption of transmission,
and provide evidence-based guidance for future surveillance
strategies in American Samoa.
Methods
Study location and setting
American Samoa consists of a group of remote islands in the
South Pacific: the main island of Tutuila, the adjacent island of
Aunu’u, and the remote Manu’a group of islands (Ta’u, Ofu, and
Olosega). The census population in 2010 was approximately
56,000 [22], with over 90% residing on Tutuila, mostly in coastal
villages. American Samoa has a tropical climate and is one of the
wettest inhabited places in the world (average annual rainfall of
over 3,000 mm), with rugged islands that include mountains,
valleys, tropical rainforests, wetlands, fringing reefs, and lagoons.
Wuchereria bancrofti is the only filarial worm species found in
American Samoa, and mosquito vectors include the highly
efficient day-biting Aedes polynesiensis and night-biting Aedes
samoanus.
Serum bank and associated data
A serum bank was collected for a leptospirosis study in
American Samoa in 2010 (four years after the last effective round
of MDA for LF), and detailed description of the study design has
been previously reported [23,24]. Briefly, in Tutuila and Aunu’u,
the study used a spatial sampling method that systematically
selected households from a geo-referenced database of all houses
on the islands. Sampling was designed to ensure maximum spatial
dispersion over the study area to optimise geospatial analysis. In
the very sparsely populated Manu’a Islands, the spatial sampling
method was impractical, and non-random convenience sampling
was used. The study included 807 adults (aged 18 to 87 years,
52.4% males) from 659 households in 55 villages on all five
inhabited islands; 721 (89.3%) lived on the main island of Tutuila,
and 555 (68.8%) had lived in American Samoa for their entire life.
During the serum bank collection, the primary place of residence
of each participant was geo-located using detailed village maps
obtained from the American Samoa GIS User Group [25].
Questionnaires were used to obtain demographic data from
participants, and were conducted by a team of interviewers who
were fluent in both English and Samoan. The serum bank was
highly representative of the adult population of American Samoa
in both age and geographic distribution. Table 1 provides a
summary of the demographics of the study population.
Ethics approval and informed consent
For the original leptospirosis study, approvals were obtained
from the American Samoa Institutional Review Board (ASIRB),
the Medical Research Ethics Committee of The University of
Queensland (MREC-UQ), and the Queensland Health Forensic
and Scientific Services Human Ethics Committee. The study was
conducted in collaboration with the American Samoa Department
of Health, and permissions for village visits were sought from the
Department of Samoan Affairs and village chiefs and/or mayors.
The study included only adult participants, all of whom provided
written informed consent. For the current study, additional
approvals to use the serum bank for lymphatic filariasis research
were obtained from ASIRB and MREC-UQ.
Serological analysis
All serological analyses were conducted at the WHO Collab-
orating Centre for Lymphatic Filariasis, Soil-transmitted Hel-
minths, and other Neglected Tropical Diseases at James Cook
University, Cairns, Australia. For all assays, sera were tested in
duplicate. For any samples where the duplicates showed greater
than 15% coefficient of variation in optical density (OD) reading,
tests were repeated, as were those on plates with unsatisfactory
standard curves or OD of less than 1.0 in the highest standard
group. All plates were read using a VersaMax tunable ELISA
reader (Molecular Devices) using Softmax Pro v5.3 software.
Og4C3 antigen ELISA test. This test detects circulating
filarial antigen (CFA) in peripheral blood produced by adult filarial
worms in the lympatics. ELISA kits from TropBio Pty Ltd, JCU,
Townsville were used (now marketed by Cellabs Pty Ltd; www.
cellabs.com.au) following manufacturer’s instructions. Sera were
diluted 1:4 in sample diluent, and incubated overnight at 4 degrees
Celsius. Known moderate positive (pool of ten samples from
Papua New Guinea (PNG)) and negative sera (laboratory members
who had never resided in LF-endemic areas) were included on
each plate. A unit value for each sample based on a standard curve
starting at an arbitrary 32,000 units with 4-fold dilutions. Two
separate cutoff points were used: Og4C3 antigen .128 units
(positive according to manufacturer’s instructions), and .32 units
(positive and equivocal). The mean value recorded for the negative
sera over 20 plates was 4.9 units.
Wb123 antibody ELISA test. The test detects antibody to
the Wb123 antigen identified from a library generated from L3
larval stages of W.bancrofti [26]. The assay was performed in
ELISA format using plates pre-coated with 10 mg/mL Wb123
antigen. Sera at 1:50 dilution in PBS/1%BSA/0.05% Tween 20
(PBS/T) were added at 50 mL per well, 50 mL of a known positive
control were added at 1:500 (high positive) and 1:5000 (low
positive) while negative control serum was added at 1:50. Plates
were incubated for 30 minutes at room temperature, washed 6
times in PBS/T and 50 mL per well of HRP conjugated mouse
anti-human IgG4 (Invitrogen A10654) at 1:5000 dilution was
added for 45 minutes incubation. After 6 washes TMB substrate
was added at 50 mL per well and the reaction was stopped with 1
M HCl after 5 minutes in the dark. Plates were read at 450 nm.
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Samples were classed as positive if their average optical density
(OD) ratio was 9 or more times the negative control (based on the
average ratio of of the low positive 1:5000 serum control to blank).
The mean OD ratio of the negative control to blank over 19 plates
was 1.0.
Bm14 antibody ELISA test. The test detects antibody to an
antigen identified from a cDNA library screened using sera from
microfilaria positive people [27]. Sera were tested at 1:50 dilution
using the method described by [27] and [12]. A known positive
control from PNG (S19) and negative serum from lab members
were included on each plate. A 7-point standard curve in duplicate
using a known high positive serum from PNG (S200) starting at
1:200 dilution (1000 arbitrary units) and then 2–fold serial
dilutions in PBS/T was included on each plate. A 4-parameter
calibration curve was used to estimate the units of Bm14 antibody
per sample. The cutoff for positivity was 125 units determined
empirically as described by [27] using known positive and negative
serum panels.
Statistical analysis
Outcome measures used for statistical analyses were ELISA test
results for each LF antigen and antibody. For Og4C3 antigen,
statistical analyses were performed using two different cutoff
points: .128 units (positive results) and .32 units (equivocal and
positive results). Independent variables assessed included age, sex,
years lived in American Samoa, occupation, household income,
and island of residence. The number of years lived in American
Samoa was categorized into ,5 years (to reflect those who did not
live in American Samoa during local MDA activities from 2000 to
2006), 5–10 years (those who lived in Am Sam during some of the
local MDA activities), and .10 years (those who lived in Am Sam
during all of the MDA activities). Occupation groups were
categorized into those who worked i) predominantly indoors, ii)
predominantly outdoors, iii) tuna cannery workers (the largest
non-government employer in American Samoa; .90% of
employees are migrant workers), and iv) others (including
unemployed, unknown occupation, and those who have jobs that
include both indoor and outdoor work). Data on household
income was available in four categories. Island of residence was
categorized into Tutuila and other islands.
The serum bank consisted of samples and data on 807
participants. There was sufficient serum in 805 samples to perform
ELISA for Og4C3 antigen, and in 806 samples for Wb123 and
Bm14 antibodies. Data on gender were available for 803
participants, on age for 798, on years lived in American Samoa
for 800, and on household income for 679. Island of residence and
geo-locations of households were available for all participants.
Chi-squared or Fisher exact tests were used to compare
outcomes for categorical independent variables. Variables with
p,0.1 were selected for further analyses using univariate logistic
regression, and odds ratios (OR) were calculated. STATA v11.1
software (StataCorp, College Station, Texas) was used for all
analyses, and p values of ,0.05 were considered to indicate
statistical significance.
Analysis of geographical clustering of serological
indicators
During the serum bank collection, the primary place of
residence of each participant was geo-located using village maps
produced using geo-referenced data from the American Samoa
GIS User Group [25]. Data available included island/village
boundaries, and the location of houses, schools, churches and
major infrastructure. For spatial analyses, only data from the main
island of Tutuila were included. Populations and inhabited areas
on Aunu’u and the Manu’a islands were too small for geospatial
analysis to be meaningful. Maps were produced to show the
distribution of participants’ households, and locations of partici-
pants with positive ELISA for each antigen and antibody. The
spatial distribution of participants based on years lived in
American Samoa was also examined to determine if migrants
were concentrated in any villages. All geo-spatial data were
collated, stored, linked and mapped using ArcMap v10.0
(Environmental Systems Research Institute, Redlands, CA).
Spatial dependence in the positive serological results for each
antigen and antibody was investigated using a semivariogram in
the statistical software R, using the geoR package version 2?14?1
(The R foundation for statistical computing). A semivariogram is a
graphical representation of the spatial variation which allows for
the quantification of spatial cluster size and the tendency for
geographical clustering within a region. The semivariogram is
characterized by three parameters: the sill, which is the spatially
structured component of the semivariance (indicative of the
tendency for geographical clustering); the nugget, which is the
spatially unstructured component of the semivariance (represent-
ing random variation, very small-scale spatial variability or
measurement error); and the range, which is the distance at
which locations can be considered independent (indicative of the
size of geographical clusters). To estimate the proportion of the
variation that was spatially structured we divided the partial sill by
the sum of the partial sill and nugget.
Results
Seroprevalence
Og4C3 antigen levels of .128 units (positive result) were found
in 0.75% (6 persons, 95% CI 0.3–1.6%) of participants, and levels
of .32 units (equivocal plus positive results) in 3.2% (26 persons,
95% CI 0.6–4.7%). The seroprevalence of Wb123 and Bm14
antibodies were 8.1% (65 positives, 95% CI6.3–10.2%) and 17.9%
(144 positives, 95% CI 15.3–20.7%) respectively.
Factors associated with positive LF antigen and
antibodies
Table 1 provides a summary of the associations between
demographic variables and the presence of LF antigen and
antibodies. Our results show that both antigen and antibody
prevalence were higher in males compared to females (Table 1).
Figure 1 shows the age distribution of participants, and the
prevalence of antigen (Og4C3.128 and Og4C3.32) and
antibodies (Wb123 and Bm14) in each age group. Antigen-
positive individuals were identified in all age groups, with no
significant difference between ages. Prevalence of both Wb123 and
Bm14 antibodies were higher in the older age groups. In
participants aged 30 years and older, Bm14 prevalence was two
to three times higher than Wb123 prevalence in all age groups.
Antibody and antigen prevalence were inversely associated with
the number of years lived in American Samoa (Figure 2 and
Table 1). Of all study participants, 68.8% (n= 555) had lived in
American Samoa for all of their lives. Compared to individuals
who had lived in American Samoa for over 10 years, new migrants
who had lived there for ,5 years had odds ratios of 13.7 (95% CI:
2.4–78.4) of having Og4C3 antigen of .128 units, and odds ratio
of 6.1 (95% CI: 1.9–19.4) of having Og4C3 antigen of .32 units
(Table 1). New migrants also had higher prevalence of Wb123 and
Bm14 antibodies compared to those who had lived in American
Samoa for .10 years, but differences were not statistically
significant. The prevalence of antibodies and antigen were higher
in residents on the main island of Tutuila compared to those who
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lived in smaller islands, but differences were not statistically
significant. Tuna cannery workers had significantly higher
prevalence of Wb123 antibodies, but there were no other
associations between occupational groups and seroprevalence.
Our study did not find any association between income and
seroprevalence.
Figure 1. Prevalence of filarial antigen and antibodies by age groups, American Samoa 2010.
doi:10.1371/journal.pntd.0003297.g001
Figure 2. Prevalence of filarial antigen and antibodies by years lived in American Samoa.
doi:10.1371/journal.pntd.0003297.g002
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Geographical clustering of serological indicators
For reference, a kernel density map of population distribution in
American Samoa is shown in Figure 3 (reproduced from [23]).
The household locations of individuals with positive and negative
Bm14 and Wb123 antibodies are shown in Figure 4a and 4b, and
positive/equivocal Og4C3 levels shown in Figures 5a and 5b.
High resolution maps of the villages of Fagalii (Figure 6a) and Ili’ili
(Figure 6b) show the locations of participants’ households, those
with positive/equivocal results for Og4C3, and the location of the
elementary school where two ICT-positive children were identified
during the 2011 Transmission Assessment Survey.
While the semivariograms for Wb123 and Bm14 antibodies did
not reveal any significant small-scale spatial variation, the
semivariograms for antigen (both Og4C3.128 units and
Og4C3.32 units) showed considerable residual spatial variation
(Figure 7 and Table 2). Our results indicate that the average size
of a cluster for Og4C3.128 units was 1,242 metres and the
proportion of the variation in Og4C3.128 units explained by
geographical proximity was 85%. The average size of a cluster for
Og4C3.32 units was 1,498 meters and the proportion of the
variation in Og4C3.32 units explained by geographical proxim-
ity was 62%. Migrants who had lived in American Samoa for ,5
Figure 3. Population distribution on the islands of American Samoa 2010 (Reproduced from Lau et al. (23).
doi:10.1371/journal.pntd.0003297.g003
Figure 4. Household locations of individuals with positive and negative antibodies on Tutuila. A. Wb123, B. Bm14.
doi:10.1371/journal.pntd.0003297.g004
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years and 5–10 years were dispersed throughout the territory, and
no significant clustering was found.
Discussion
Our study demonstrates that high-risk populations for LF in
American Samoa include adult males and recent migrants. The
results also suggest the possible existence of residual foci of
antigen-positive individuals in American Samoa. Although our
findings do not provide conclusive evidence of recent transmission,
further investigation is recommended to confirm (or otherwise) the
possible high-risk populations and locations, and determine
whether ongoing targeted surveillance of these groups is warrant-
ed, particularly in the Samoan Islands where there is a history of
resurgence despite achieving very low prevalence [4].
The prevalence of Wb123 and Bm14 antibodies differed
significantly, and further research is required to understand the
role of each laboratory test in post-MDA surveillance. There was a
sharp rise in Bm14 antibody prevalence from age 30–39 years,
which was also observed by Mladonicky et al in 2006 in three
villages of American Samoa [9]. We found that Wb123 antibody
prevalence peaked in participants aged between 30 and 40 years,
but at much lower prevalence than Bm14 antibody. Wb123
antibody is a relatively new assay, and the indicative cutoff point
used in this study could have contributed to the differences
between the prevalence of Wb123 and Bm14 antibodies. Neither
Wb123 nor Bm14 antibody prevalence declined with age, but at
present we cannot distinguish long-term persistence of antibodies
from ongoing transmission. Other studies have noted persistence
of Wb123 antibodies in adults for many years after MDA,
although significant decline was observed in those who were
antigen-negative [28].
Positive Og4C3 antigen was found in all age groups and did not
show any age-specific patterns. The presence of Og4C3 is not
necessarily associated with microfilaraemia and does not provide
evidence of ongoing transmission. Antigen prevalence drops
Figure 5. Household locations of individuals with positive and negative antigen on Tutuila. A. Og4C3.128 units, B. Og4C3.32 units.
doi:10.1371/journal.pntd.0003297.g005
Figure 6. High resolution village maps of A. Fagali’I and B. Ili’ili, showing household locations of individuals with Og4C3 antigen of
.128 units and .32 units, and school where two ICT-positive children identified in 2011 TAS.
doi:10.1371/journal.pntd.0003297.g006
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Figure 7. Semivariograms of spatial dependence of antigen and antibodies: A. Og4C3.128 units, B. Og4C3.32 units, C. Wb123
positive, D. Bm14 positive.
doi:10.1371/journal.pntd.0003297.g007
Table 2. Spatial parameters of geographical clustering of Og4C3 antigen, and Wb123 and Bm14 antibodies.
Spatial parameters Og4C3.128 Og4C3.32 Wb123 Bm14
Range (meters) 1,242 1,498 60 NA
Partial sill 0.00965 0.0451 0.015 NA
Nugget 0.00173 0.0281 0.075 NA
Proportion of variance due to spatial dependence (%) 85 62 17 NA
doi:10.1371/journal.pntd.0003297.t002
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dramatically after MDA, but it is not possible to unequivocally
distinguish between recent or past infection based on Og4C3
alone. However, for W. bancrofti areas, the WHO currently
supports the use of circulating filarial antigen prevalence
(measured by ICT card test) as an indicator of LF infection, and
it is one of the options of diagnostic tests used for measuring the
prevalence of infection at each stage of the elimination process
(pre-MDA mapping, sentinel and spot check sites, and TAS). The
Og4C3 antigen has also been used in a similar study in Haiti that
investigated clustering of residual antigen-positive persons in low
endemic areas [19].
In our study, three aspects of the Og4C3-positive individuals
raised suspicion about the possibility of recent transmission. Firstly,
one cluster of Og4C3-positive adults was located in very close
proximity to the two ICT-positive children found during the 2011
TAS. Secondly, Og4C3 prevalence in our study was higher in
migrants (mostly from Samoa) even though baseline antigen
prevalence in 1999 was much lower in Samoa (4.5%) than
American Samoa (16.5%). If positive Og4C3 in our sample
predominantly reflected infections in the remote past, prevalence
would be expected to be lower in the migrants. Thirdly, we found
significant spatial clustering of Og4C3 antigen, but not of Wb123
or Bm14 antibodies. If the Og4C3-positive adults in our study
were predominantly infected in the remote past, clustering would
have been much less likely, as demonstrated by the absence of
clustering of antibody-positive adults.
Data on microfilaraemia would have helped determine the
presence of ongoing transmission, but this was not possible with a
serum bank. Despite this limitation, we believe that our
seroprevalence study of adults provided valuable information
about potential residual infections in American Samoa. Similar
studies should be considered elsewhere for post-MDA surveillance
and for identifying high-risk populations and/or locations that
might warrant more intense targeted surveillance.
Higher LF seroprevalence in males corroborates findings from
some of the previous studies in Samoa [7,18] and American
Samoa [29], and could be explained by more time spent outdoors
for work and recreation compared to females. Interestingly, LF
prevalence was found to be equivalent in males and females in
1999 prior to MDA in American Samoa, but Liang et al. reported
a shift toward higher prevalence in males in sentinel site surveys
conducted during and after MDA [29]. Our study (using a much
larger and more representative sample of the adult population)
confirms the higher prevalence among males post-MDA in
American Samoa.
Our results also indicate higher antigen prevalence in new
migrants, who were mostly from a neighbouring LF-endemic
country where transmission is still occurring in some areas. This
suggests that human movement could be an important pathway
for parasite reintroduction and subsequent resurgence of LF in
American Samoa. Visitors and migrants travel for family, work,
and economic reasons and usually live and work in close proximity
to local American Samoans. Prolonged visits and cross migration
are also common, and further increase the chances of parasite
reintroduction. In addition, American Samoans also travel
frequently to Samoa and other neighbouring Pacific Islands, and
could be at significant risk of infection if staying for extended
periods in areas of high prevalence. In 2012, there were a total of
67,979 international arrivals to American Samoa (with a local
population of ,56,000). Of these 44,830 were citizens of other
Pacific Islands, including 22,600 arrivals of returning citizens of
American Samoa. A total of 20,082 arrivals were Samoan citizens,
with 158 travelling for business, 4,158 for employment, 7,123
returning residents, and 8,757 visiting relatives [22]. Further
research is required to improve understanding of the role of
human movement in parasite reintroduction into American
Samoa, and the consequent risk of resurgence based on travel
patterns between Samoa and American Samoa, and LF preva-
lence at places of origin of visitors and new migrants. Cross-border
strategies to coordinate efforts between Samoa and American
Samoa for LF elimination and surveillance should also be
considered.
American Samoa’s population mostly live on ancestral land, and
most of the study participants had lived in the same village for
most or all of their lives, thus providing an excellent opportunity to
examine disease transmission patterns. Our results indicate that
most of the spatial distribution of antigenaemia could be
accounted for by geographical proximity of place of residence.
Geo-spatial analysis provided some evidence of possible micro-
spatial clustering of antigen-positive adults at the neighborhood
level at two villages. Clustering at the household level suggests that
the home environment is important in transmission even though
one of the major vectors is day-biting. The close proximity
between the elementary school attended by the two ICT-positive
young children identified during the 2011 TAS and one of the
possible village clusters suggests possible ongoing transmission.
Our results indicate an average cluster size of 1,200 meters to
1,500 meters for antigenaemia, and the estimate of cluster size
provides important information for the design of further studies to
identify local transmission foci.
Our study demonstrates the potential value of geospatial
databases in post-intervention surveillance, monitoring, and
evaluation for identifying possible micro-spatial clusters that might
not be captured by routine TAS alone. Early detection of such
clusters could be essential for timely intervention to reduce the risk
of resurgence. Geospatial analysis could therefore potentially be
used as an additional tool for verifying elimination status and for
confirming that transmission has been interrupted. Changes in the
spatial distribution of serological markers over time would also
potentially be useful for identifying focal transmission, but
unfortunately results of previous surveys in American Samoa were
only located to the village rather than household level, and not of
sufficiently high spatial resolution for the types of analyses
conducted in this study or for comparing changes over time.
Further operational research could also explore the use of
geospatial data for informing programme delivery (e.g. by
identifying the size of clusters and delineating areas that might
warrant targeted surveillance and monitoring); calculating the
distance of influence on infection risk that antigen-positive persons
have on their near neighbours; and determining transmission
threshold targets that include a spatial component rather than just
a simple average prevalence for an entire evaluation unit. The
accuracy of prevalence estimations in evaluation units will also
depend on spatial heterogeneity within the boundaries of the unit.
Risk of LF and drivers of transmission are unlikely to be entirely
uniform within any evaluation units, and be determined by many
factors such as climatic conditions, population density, urban
versus rural areas, MDA coverage, and vector species and density.
The average prevalence in an evaluation unit could therefore mask
focal areas of high prevalence (hotspots) if they are surrounded by
large areas of low prevalence. Consequently, estimations of
average prevalence in an area could vary greatly depending on
how evaluation units were determined. Hotspots are more likely to
be missed if they are small, in evaluation areas with greater spatial
heterogeneity in risks and drivers, and when prevalence is very low
such as in the post-MDA surveillance phase. Careful definition of
evaluation units will therefore be crucial for optimising the
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probability of identifying any residual hotspots of transmission or
early resurgence.
One of the challenges pertaining to geospatial methods of
cluster detection when utilising point location data is that such
data are prone to random error and random variation in the
presence of rare disease events and/or inadequate representation
of the population at risk. We therefore used a robust geostatistical
method to identify the presence of geographical clustering in our
point location data by partitioning the variation in data that was
due to random error and the variation that is due to spatial
clustering. Semivariography (as utilized in this study) demonstrated
that spatial clustering was present in the study area (Tutuila) but
does not identify the location of clusters. The location of clusters
could be further investigated by using model-based geostatistics
that account for diagnostic uncertainty and variation in factors
such as climate, population, and entomological parameters to
produce predictive risk maps of LF.
Spatial decision support systems are being used for malaria
elimination programs, and similar tools could also be useful for LF
[30]. A geospatial platform could also be used to integrate
environmental and entomological data with human surveillance
data, and used to explore possible environmental drivers of disease
transmission, the impact of vector control on elimination
programs, and the potential for using xenomonitoring to enhance
post-MDA surveillance.
This study also demonstrates the usefulness of high-quality serum
banks for investigating multiple diseases (a dengue seroprevalence
study was also conducted using the same serum bank [31]), and
provides an example of successful collaboration between researchers
of different diseases to improve the cost-effectiveness of field
epidemiology investigations, which are often expensive and
logistically challenging. We believe that the WHO’s recommenda-
tions of integrating of LF surveillance activities with other
population-based surveys are logistically feasible and practical.
Our findings should be interpreted in light of potential
limitations. First, the serum bank used for the study was collected
for a leptospirosis study, and we could not ascertain whether
participants had previously been diagnosed with or treated for LF,
or participated in MDA in American Samoa or elsewhere. Only
28 participants (3.9%) were recent migrants (lived ,5 years in
American Samoa), and although they would not have been living
in American Samoa during MDA activities, some might have
received MDA in Samoa or other home countries. However, we
have no reason to believe that our participants were biased with
respect to MDA compliance locally or elsewhere. Second, there
were only six participants with Og4C3 of .128 units, and 26
participants with Og4C3 of .32 units, and small numbers could
have affected the accuracy of spatial analyses. Small numbers
generally reduce the likelihood of identifying statistically significant
associations, but despite this, we found significant results using
robust tests and geospatial analyses. Third, participants in the
serum bank included adults of all ages, but did not include
children or adolescents. Results of TAS conducted at about the
same time provided antigen prevalence data in 6–7 year old
children, but data on antigen and antibody levels in children of all
ages would help improve understanding of the application of
diagnostic tests for post-MDA surveillance. Finally, participants
were geo-located to place of residence, but LF infection could
occur elsewhere, particularly in the presence of efficient day-biting
vectors. If vectors were predominantly night-biting, clustering of
infections could potentially be even more readily defined around
household locations.
This study provides preliminary results to support the impor-
tance of further research designed to specifically focus on
improving understanding of disease transmission at the last stages
of elimination when prevalence is very low; answering operational
questions in LF elimination programs, especially the role of
migration; developing tools to enhance the effectiveness of post-
MDA surveillance and monitoring; and providing an evidence
base for elimination strategies and targets. Follow up studies are
being conducted in American Samoa to determine whether
hotspots truly exist, develop models to quantify the significance of
migrants in LF elimination, and explore the use of molecular
xenomonitoring in the Pacific Island setting. The study also
highlights the importance of assessing locally relevant risks for
infection, which could vary significantly between places depending
on cultural, societal, and environmental factors, as well as filarial
species and mosquito vectors. The approach and results of this
study are specifically relevant for the Samoan islands, but could
also provide insight into LF transmission in other LF-endemic
areas, and be pertinent to other Pacific Islands with similar vectors,
lifestyle, culture, climate, environmental conditions, and migration
patterns.
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